^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

DCIKKb

i
Other names: Vaccination with IKKb matured Dendritic Cells, DCIKKb, Dendritic Cell vaccine
Associations
Company:
Hasumi International Research Foundation, ICVS Tokyo Clinic
Drug class:
Immunostimulant
Related drugs:
Associations
over2years
IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma (clinicaltrials.gov)
P1, N=12, Active, not recruiting, Hasumi International Research Foundation | Recruiting --> Active, not recruiting | Trial completion date: Jun 2025 --> Jan 2024 | Trial primary completion date: Jun 2022 --> Jan 2023
Enrollment closed • Trial completion date • Trial primary completion date
|
CD4 (CD4 Molecule)
|
DCIKKb